The isolation of the first human embryonic stem cell (hESC) lines in 1998 opened the possibility of stem cell therapies for a variety of conditions. Type 1 diabetes (T1D) is particularly suited to ...
An unexpectedly versatile and regenerative stem cell in early embryos may be key to creating new effective fertility treatments, suggests a new study in mice from the University of Copenhagen. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback